The above results also signifies that up-regulated Notch-3 and down-regulated Notch-1 expression are correlated with late clinical stage of ISCC and associated with aggressive tumor behaviour and cancer progression underscoring their potential as a candidate predictive markers for disease progression. This evidence concerns the gene NOTCH1 and neoplasm.